Utama › Kanser Prostat › Montana › Billings
Kajian klinikal Kanser Prostat di Billings, MT
15 kajian untuk Kanser Prostat sedang mencari peserta di lokasi dalam dan sekitar Billings (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Mengambil pesertaFasa 3
- Billings Clinic Cancer Center, Billings
- Saint Vincent Frontier Cancer Center, Billings
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Mengambil pesertaFasa 3
- Billings Clinic Cancer Center, Billings
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Billings Clinic Cancer Center, Billings
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Mengambil pesertaFasa 2
- Billings Clinic Cancer Center, Billings
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Mengambil pesertaFasa 2
- Billings Clinic Cancer Center, Billings
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Mengambil pesertaFasa 3
- St. Vincent Frontier Cancer Center-Research ( Site 0037), Billings
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Mengambil pesertaFasa 3
- St. Vincent Frontier Cancer Center-Research ( Site 0037), Billings
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Mengambil pesertaFasa 3
- Billings Clinic Cancer Center, Billings
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Mengambil pesertaFasa 3
- Billings Clinic Cancer Center, Billings
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Mengambil pesertaFasa 3
- Billings Clinic Cancer Center, Billings
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Mengambil pesertaFasa 3
- Billings Clinic Cancer Center, Billings
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Mengambil pesertaFasa 2
- Billings Clinic Cancer Center, Billings
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Mengambil pesertaFasa 3
- Billings Clinic Cancer Center, Billings
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Billings
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Mengambil pesertaFasa 3
- Billings Clinic Cancer Center, Billings
Kajian Kanser Prostat di bandar lain
- New York City, NY103 kajian
- Houston, TX76 kajian
- Los Angeles, CA61 kajian
- Boston, MA59 kajian
- St. Louis, MO46 kajian
- Chicago, IL45 kajian
- San Francisco, CA45 kajian
- Philadelphia, PA44 kajian
- Baltimore, MD43 kajian
- Nashville, TN42 kajian
- Seattle, WA42 kajian
- Washington, DC38 kajian
Kajian lain di Billings
- Kanser Paru-paru Bukan Sel Kecil17 kajian
- Kanser Paru-paru13 kajian
- Kanser Payudara10 kajian
- Kanser Ovari9 kajian
- Melanoma7 kajian
- Leukemia Limfositik Kronik7 kajian
- Kanser Kolorektal6 kajian
- Kanser Kolon6 kajian
- Kanser Pundi Kencing6 kajian
- Leukemia Mieloid Akut6 kajian
- Kanser Rektum5 kajian
- Kanser Endometrium4 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.